Pulmatrix's Series A Round

Pulmatrix raised a round of funding on June 12, 2007.

Pulmatrix is a clinical stage biotechnology company with an inhaled dry powder platform advancing a new generation of inhaled therapeutics. The platform, called iSPERSE (inhaled small particles easily…

Articles about Pulmatrix's Series A Round: